Bordetella pertussis antigens

Boostrix

Form: solution for injection in ampoule-syringe

Active substance	Dosage
diphtheria toxoid	No input provided
tetanus toxoid	No input provided
Bordetella pertussis antigens	No input provided

Form: solution for injection in ampoule-syringe

Active substance	Dosage
diphtheria toxoid	> or equal to 2 IU (2.5 Lf)
aluminum phosphate	0.2 mg Al 3+
inactivated poliovirus type 1	40 units of antigen D
inactivated poliovirus type 2	8 units of antigen D
inactivated poliovirus type 3	32 units of antigen D
tetanus toxoid	> or equal 20 IU (5 Lf)
aluminum hydroxide hydrate	0.3 mg Al 3+
Bordetella pertussis antigens	8 mcg + 8 mcg + 2.5 mcg

Form: powder and suspension for preparation of injection suspension

Active substance	Dosage
diphtheria toxoid	No input provided
tetanus toxoid	No input provided
Bordetella pertussis antigens	No input provided
inactivated poliovirus types 1, 2 and 3	No input provided
Haemophilus b polysaccharide conjugated with tetanus toxoid	No input provided

Form: powder and suspension for preparation of injection suspension

Active substance	Dosage
Inactivated poliovirus type 1	40 units of antigen D
Inactivated poliovirus type 2	8 units of antigen D
Inactivated poliovirus type 3	32 units of antigen D
Haemophilus influenzae type b conjugated polysaccharide-tetanus toxoid conjugate	10 mcg
Diphtheria toxoid	not less than 30 IU
Tetanus toxoid	not less than 40 IU
Bordetella pertussis antigens	25 mcg + 25 mcg

Form: solution for injection in ampoule-syringe

Active substance	Dosage
diphtheria toxoid	minimum 30 IU
tetanus toxoid	minimum 40 IU
Bordetella pertussis antigens	25 micrograms
poliovirus type 1 Mahoney strain inactivated	40 units of antigen D
poliovirus type 2 MEF-1 strain inactivated	8 units of antigen D
poliovirus type 3 Sabin strain inactivated	32 units of antigen D